Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Messer

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Pharmaceutica Acta Helvetiae|May 17, 2000
Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptorsW S Messer, W G Rajeswaran, Y Cao, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
HMGB1 acts as an agent of host defense at the gut mucosal barrierA-M C Overstreet, B Anderson, M Burge, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 19, 2012
Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitisLesley Rhee, Stephen F Murphy, Lauren E Kolodziej, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 20, 2014
Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient miceStephen F Murphy, Lesley Rhee, Wesley A Grimm, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Evidence that extracellular HSPB1 contributes to inflammation in alcohol-associated hepatitisAnne-Marie C Overstreet, McKenzie Burge, Annette Bellar, et al.
Journal of Neurochemistry|June 6, 2025
Multi-Omic Analysis of Glutamate Excitotoxicity in Primary Neuronal CulturesJennifer H Nguyen, Xiaolu Zhang, Hunter M Eby, et al.
Journal of Medicinal Chemistry|April 11, 1997
Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonistsW S Messer, Y F Abuh, Y Liu, et al.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Gut|February 4, 2015
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferonWesley A Grimm, Jeannette S Messer, Stephen F Murphy, et al.
Frontiers in Immunology|July 4, 2018
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931M Fevzi Ozkaynak, Andrew L Gilman, Wendy B London, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Pharmaceutica Acta Helvetiae|May 17, 2000
Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptorsW S Messer, W G Rajeswaran, Y Cao, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
HMGB1 acts as an agent of host defense at the gut mucosal barrierA-M C Overstreet, B Anderson, M Burge, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 19, 2012
Expression of TNFAIP3 in intestinal epithelial cells protects from DSS- but not TNBS-induced colitisLesley Rhee, Stephen F Murphy, Lauren E Kolodziej, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 20, 2014
Intestinal epithelial expression of TNFAIP3 results in microbial invasion of the inner mucus layer and induces colitis in IL-10-deficient miceStephen F Murphy, Lesley Rhee, Wesley A Grimm, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Evidence that extracellular HSPB1 contributes to inflammation in alcohol-associated hepatitisAnne-Marie C Overstreet, McKenzie Burge, Annette Bellar, et al.
Journal of Neurochemistry|June 6, 2025
Multi-Omic Analysis of Glutamate Excitotoxicity in Primary Neuronal CulturesJennifer H Nguyen, Xiaolu Zhang, Hunter M Eby, et al.
Journal of Medicinal Chemistry|April 11, 1997
Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonistsW S Messer, Y F Abuh, Y Liu, et al.
JCI Insight|September 22, 2017
Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancerFumi Sato-Kaneko, Shiyin Yao, Alast Ahmadi, et al.
Gut|February 4, 2015
The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferonWesley A Grimm, Jeannette S Messer, Stephen F Murphy, et al.
Frontiers in Immunology|July 4, 2018
A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931M Fevzi Ozkaynak, Andrew L Gilman, Wendy B London, et al.
Pageof 14